GSK Market Cap

GSK has a market cap or net worth of $99.15 billion as of October 15, 2026. Its market cap has increased by 12.09% in one year.

Market Cap

99.15B

Enterprise Value

118.50B

1-Year Change

12.09%

Global Rank

n/a

Country Rank

n/a

ChartMarket Cap Chart

Chart

Since December 1, 1998, GSK's market cap has decreased from $159.34B to $99.15B, a decrease of -37.77%. That is a compound annual growth rate of -1.69%.

Market Cap History

Date	Market Cap	% Change
Oct 13, 2026	92.70B	-6.28%
Dec 31, 2025	98.91B	44.25%
Dec 31, 2024	68.57B	-8.74%
Dec 29, 2023	75.14B	6.12%
Dec 30, 2022	70.81B	-35.88%
Dec 31, 2021	110.43B	20.28%
Dec 31, 2020	91.81B	-21.29%
Dec 31, 2019	116.64B	23.14%
Dec 31, 2018	94.72B	8.77%
Dec 29, 2017	87.08B	-7.13%
Dec 30, 2016	93.77B	-4.44%
Dec 31, 2015	98.13B	-5.42%
Dec 31, 2014	103.75B	-21.06%
Dec 31, 2013	131.43B	19.76%
Dec 31, 2012	109.74B	-7.43%
Dec 30, 2011	118.55B	16.46%
Dec 31, 2010	101.79B	-7.10%
Dec 31, 2009	109.58B	17.51%
Dec 31, 2008	93.25B	-31.55%
Dec 31, 2007	136.24B	-6.62%
Dec 29, 2006	145.90B	52.77%
Dec 31, 2002	95.50B	-24.81%
Dec 31, 2001	127.01B	-11.04%
Dec 29, 2000	142.77B	0.22%
Dec 31, 1999	142.45B	-19.60%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
AbbVie	500.94B
Merck & Co.	363.59B
Novartis AG	277.86B
AstraZeneca	250.87B
Amgen	230.37B
Gilead Sciences	190.38B
Novo Nordisk	168.42B
Pfizer	166.49B

Market Cap Rankings